Article Correctness Is Author's Responsibility: Clinical trial to study psilocybin therapy for depression in cancer patients

(The Reis Group) The first clinical trial to test the safety and feasibility of psilocybin therapy with simultaneous group administration and one-on-one patient support to treat depression in cancer patients was launched today by Maryland Oncology Hematology at the Aquilino Cancer Center at Adventist HealthCare Shady Grove Medical Center. A lead therapist will oversee groups of two to four patients receiving a synthetic form of psilocybin, with constant one-on-one attention from trained therapists.